Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Dacarbazine recalled?

Not under an active recall. Dacarbazine was recalled 4 times in the past — all now closed. Most recent: Feb 10, 2021.

Most common reason: Sterility / contamination (2 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Dacarbazine. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Dacarbazine recalls on record

none so far in 2026; 4 on record, newest first
Class II · Moderate risk

Dacarbazine for Injection USP

Lack of Assurance of Sterility: manufacturing areas for the recalled products exceeded acceptance levels for microbial recovery leading to a lack of sterility assurance for these sterile injectable products.

Terminated Sterility / contamination Teva Pharmaceuticals USA NDC 0703-5075-01 D-0271-2021
Class III · Low risk

Dacarbazine

Discoloration: Reconstituted solution may appear pink instead of colorless to pale yellow when stored per the labeled conditions.

Terminated Failed specification Hospira Inc. NDC 61703-327-22 D-0313-2015
Class II · Moderate risk

Dacarbazine active pharmaceutical ingredient packaged in varying…

Penicillin Cross Contamination: All lots of all products repackaged and distributed between 01/05/12 and 02/12/15 are being recalled because they were repackaged in a facility with penicillin products without adequate separation which could introduce the potential for cross contamination with penicillin.

Terminated Cross-contamination Attix Pharmaceuticals D-609-2015